AustralieFrV1, Main, Exploration, bibRecord, 002957

Progression-free survival by local investigator versus independent central review: comparative analysis of the AGO-OVAR16 Trial.

Identifieur interne : 002957 ( Main/Exploration ); précédent : 002956; suivant : 002958

Progression-free survival by local investigator versus independent central review: comparative analysis of the AGO-OVAR16 Trial.

Auteurs : Anne Floquet [France] ; Ignace Vergote [Belgique] ; Nicoletta Colombo [Italie] ; Bent Fiane [Norvège] ; Bradley J. Monk [États-Unis] ; Alexander Reinthaller [Autriche] ; Paula Calvert [Irlande (pays)] ; Thomas J. Herzog [États-Unis] ; Werner Meier [Allemagne] ; Jae-Weon Kim [Corée du Sud] ; Josep M. Del Campo [Espagne] ; Michael Friedlander [Australie] ; Carmela Pisano [Italie] ; Seiji Isonishi [Japon] ; Rocco J. Crescenzo [États-Unis] ; Catherine Barrett [Royaume-Uni] ; Karrie Wang [États-Unis] ; Ionel Mitrica [États-Unis] ; Andreas Du Bois [Allemagne]

Source :

Gynecologic oncology [ 1095-6859 ] ; 2015.

RBID : pubmed:25434635

Descripteurs français

English descriptors

KwdEn :
- Angiogenesis Inhibitors, Disease-Free Survival, Double-Blind Method, Endpoint Determination (methods), Endpoint Determination (standards), Fallopian Tube Neoplasms (drug therapy), Fallopian Tube Neoplasms (mortality), Fallopian Tube Neoplasms (surgery), Female, Humans, Neoplasms, Glandular and Epithelial (drug therapy), Neoplasms, Glandular and Epithelial (mortality), Neoplasms, Glandular and Epithelial (surgery), Ovarian Neoplasms (drug therapy), Ovarian Neoplasms (mortality), Ovarian Neoplasms (surgery), Peritoneal Neoplasms (drug therapy), Peritoneal Neoplasms (mortality), Peritoneal Neoplasms (surgery), Pyrimidines (therapeutic use), Sulfonamides (therapeutic use).
MESH :
- chemical , therapeutic use : Pyrimidines, Sulfonamides.
- chemical : Angiogenesis Inhibitors.
- drug therapy : Fallopian Tube Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Peritoneal Neoplasms.
- methods : Endpoint Determination.
- mortality : Fallopian Tube Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Peritoneal Neoplasms.
- standards : Endpoint Determination.
- surgery : Fallopian Tube Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Peritoneal Neoplasms.
- Disease-Free Survival, Double-Blind Method, Female, Humans.

Abstract

Analysis of progression-free survival (PFS) as the primary endpoint in advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer (AEOC) trials may be confounded by the difficulty of radiologic evaluation of disease progression and the potential for discrepancy between investigator and blinded independent central assessments. PFS as assessed by local investigator (INV) was the primary endpoint of AGO-OVAR16, a randomized, double-blind trial of pazopanib maintenance therapy in AEOC. To confirm the robustness of the primary analysis, PFS was also evaluated by blinded independent central review (BICR).

DOI: 10.1016/j.ygyno.2014.11.074
PubMed: 25434635

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Progression-free survival by local investigator versus independent central review: comparative analysis of the AGO-OVAR16 Trial.</title>
<author><name sortKey="Floquet, Anne" sort="Floquet, Anne" uniqKey="Floquet A" first="Anne" last="Floquet">Anne Floquet</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut Bergonié, Bordeaux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Bergonié, Bordeaux</wicri:regionArea>
<placeName><region type="region">Nouvelle-Aquitaine</region>
<region type="old region">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vergote, Ignace" sort="Vergote, Ignace" uniqKey="Vergote I" first="Ignace" last="Vergote">Ignace Vergote</name>
<affiliation wicri:level="1"><nlm:affiliation>University Hospitals Leuven, Dept. of Gynaecological Oncology, Leuven, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>University Hospitals Leuven, Dept. of Gynaecological Oncology, Leuven</wicri:regionArea>
<wicri:noRegion>Leuven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Colombo, Nicoletta" sort="Colombo, Nicoletta" uniqKey="Colombo N" first="Nicoletta" last="Colombo">Nicoletta Colombo</name>
<affiliation wicri:level="3"><nlm:affiliation>University of Milan Bicocca and European Institute of Oncology, Gynecologic Oncology, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>University of Milan Bicocca and European Institute of Oncology, Gynecologic Oncology, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fiane, Bent" sort="Fiane, Bent" uniqKey="Fiane B" first="Bent" last="Fiane">Bent Fiane</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Gynecology and Gynecologic Oncology, Stavanger University Hospital, Stavanger, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Gynecology and Gynecologic Oncology, Stavanger University Hospital, Stavanger</wicri:regionArea>
<wicri:noRegion>Stavanger</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Monk, Bradley J" sort="Monk, Bradley J" uniqKey="Monk B" first="Bradley J" last="Monk">Bradley J. Monk</name>
<affiliation wicri:level="2"><nlm:affiliation>Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, Division of Gynecologic Oncology, Phoenix, AZ, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, Division of Gynecologic Oncology, Phoenix, AZ</wicri:regionArea>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Reinthaller, Alexander" sort="Reinthaller, Alexander" uniqKey="Reinthaller A" first="Alexander" last="Reinthaller">Alexander Reinthaller</name>
<affiliation wicri:level="3"><nlm:affiliation>Allgemeines Krankenhaus Wien, Dept. Gynecology and Obstetrics, Vienna, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Allgemeines Krankenhaus Wien, Dept. Gynecology and Obstetrics, Vienna</wicri:regionArea>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Calvert, Paula" sort="Calvert, Paula" uniqKey="Calvert P" first="Paula" last="Calvert">Paula Calvert</name>
<affiliation wicri:level="1"><nlm:affiliation>All-Ireland Co-operative Oncology Group, Dublin, Ireland.</nlm:affiliation>
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>All-Ireland Co-operative Oncology Group, Dublin</wicri:regionArea>
<wicri:noRegion>Dublin</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Herzog, Thomas J" sort="Herzog, Thomas J" uniqKey="Herzog T" first="Thomas J" last="Herzog">Thomas J. Herzog</name>
<affiliation wicri:level="2"><nlm:affiliation>University of Cincinnati Cancer Institute, Cincinnati, OH, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of Cincinnati Cancer Institute, Cincinnati, OH</wicri:regionArea>
<placeName><region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Meier, Werner" sort="Meier, Werner" uniqKey="Meier W" first="Werner" last="Meier">Werner Meier</name>
<affiliation wicri:level="3"><nlm:affiliation>Evangelisches Krankenhaus Düsseldorf, Düsseldorf, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Evangelisches Krankenhaus Düsseldorf, Düsseldorf</wicri:regionArea>
<placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Düsseldorf</region>
<settlement type="city">Düsseldorf</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kim, Jae Weon" sort="Kim, Jae Weon" uniqKey="Kim J" first="Jae-Weon" last="Kim">Jae-Weon Kim</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Obstetrics and Gynecology, Seoul National University, Seoul, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Seoul National University, Seoul</wicri:regionArea>
<placeName><settlement type="city">Séoul</settlement>
<region type="capital">Région capitale de Séoul</region>
<settlement type="city">Séoul</settlement>
</placeName>
<orgName type="university">Université nationale de Séoul</orgName>
</affiliation>
</author>
<author><name sortKey="Del Campo, Josep M" sort="Del Campo, Josep M" uniqKey="Del Campo J" first="Josep M" last="Del Campo">Josep M. Del Campo</name>
<affiliation wicri:level="3"><nlm:affiliation>Vall d'Hebron University Hospital, Dept. of Medical Oncology, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Vall d'Hebron University Hospital, Dept. of Medical Oncology, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Friedlander, Michael" sort="Friedlander, Michael" uniqKey="Friedlander M" first="Michael" last="Friedlander">Michael Friedlander</name>
<affiliation wicri:level="1"><nlm:affiliation>The Prince of Wales Cancer Center, Dept. of Medical Oncology, Randwick, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The Prince of Wales Cancer Center, Dept. of Medical Oncology, Randwick, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pisano, Carmela" sort="Pisano, Carmela" uniqKey="Pisano C" first="Carmela" last="Pisano">Carmela Pisano</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Uro-gynecologic Oncology, Istituto Nazionale Tumori Fondazione G Pascale-IRCCS, Naples, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Uro-gynecologic Oncology, Istituto Nazionale Tumori Fondazione G Pascale-IRCCS, Naples</wicri:regionArea>
<wicri:noRegion>Naples</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Isonishi, Seiji" sort="Isonishi, Seiji" uniqKey="Isonishi S" first="Seiji" last="Isonishi">Seiji Isonishi</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Obstetrics and Gynecology, Jikei University School of Medicine, Daisan Hospital, Tokyo, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Jikei University School of Medicine, Daisan Hospital, Tokyo</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Crescenzo, Rocco J" sort="Crescenzo, Rocco J" uniqKey="Crescenzo R" first="Rocco J" last="Crescenzo">Rocco J. Crescenzo</name>
<affiliation wicri:level="2"><nlm:affiliation>GlaxoSmithKline, Collegeville, PA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>GlaxoSmithKline, Collegeville, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Barrett, Catherine" sort="Barrett, Catherine" uniqKey="Barrett C" first="Catherine" last="Barrett">Catherine Barrett</name>
<affiliation wicri:level="1"><nlm:affiliation>GlaxoSmithKline Pharmaceuticals, Uxbridge, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>GlaxoSmithKline Pharmaceuticals, Uxbridge</wicri:regionArea>
<wicri:noRegion>Uxbridge</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wang, Karrie" sort="Wang, Karrie" uniqKey="Wang K" first="Karrie" last="Wang">Karrie Wang</name>
<affiliation wicri:level="2"><nlm:affiliation>GlaxoSmithKline, Collegeville, PA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>GlaxoSmithKline, Collegeville, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mitrica, Ionel" sort="Mitrica, Ionel" uniqKey="Mitrica I" first="Ionel" last="Mitrica">Ionel Mitrica</name>
<affiliation wicri:level="2"><nlm:affiliation>GlaxoSmithKline, Collegeville, PA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>GlaxoSmithKline, Collegeville, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Du Bois, Andreas" sort="Du Bois, Andreas" uniqKey="Du Bois A" first="Andreas" last="Du Bois">Andreas Du Bois</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Gynecology and Gynecologic Oncology, Kliniken Essen Mitte, Essen, Germany. Electronic address: prof.dubois@googlemail.com.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Gynecology and Gynecologic Oncology, Kliniken Essen Mitte, Essen</wicri:regionArea>
<wicri:noRegion>Essen</wicri:noRegion>
<wicri:noRegion>Essen</wicri:noRegion>
<wicri:noRegion>Essen</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25434635</idno>
<idno type="pmid">25434635</idno>
<idno type="doi">10.1016/j.ygyno.2014.11.074</idno>
<idno type="wicri:Area/PubMed/Corpus">003191</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003191</idno>
<idno type="wicri:Area/PubMed/Curation">003081</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003081</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003081</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003081</idno>
<idno type="wicri:Area/Ncbi/Merge">002028</idno>
<idno type="wicri:Area/Ncbi/Curation">002028</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002028</idno>
<idno type="wicri:Area/Main/Merge">002957</idno>
<idno type="wicri:Area/Main/Curation">002957</idno>
<idno type="wicri:Area/Main/Exploration">002957</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Progression-free survival by local investigator versus independent central review: comparative analysis of the AGO-OVAR16 Trial.</title>
<author><name sortKey="Floquet, Anne" sort="Floquet, Anne" uniqKey="Floquet A" first="Anne" last="Floquet">Anne Floquet</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut Bergonié, Bordeaux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Bergonié, Bordeaux</wicri:regionArea>
<placeName><region type="region">Nouvelle-Aquitaine</region>
<region type="old region">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vergote, Ignace" sort="Vergote, Ignace" uniqKey="Vergote I" first="Ignace" last="Vergote">Ignace Vergote</name>
<affiliation wicri:level="1"><nlm:affiliation>University Hospitals Leuven, Dept. of Gynaecological Oncology, Leuven, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>University Hospitals Leuven, Dept. of Gynaecological Oncology, Leuven</wicri:regionArea>
<wicri:noRegion>Leuven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Colombo, Nicoletta" sort="Colombo, Nicoletta" uniqKey="Colombo N" first="Nicoletta" last="Colombo">Nicoletta Colombo</name>
<affiliation wicri:level="3"><nlm:affiliation>University of Milan Bicocca and European Institute of Oncology, Gynecologic Oncology, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>University of Milan Bicocca and European Institute of Oncology, Gynecologic Oncology, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fiane, Bent" sort="Fiane, Bent" uniqKey="Fiane B" first="Bent" last="Fiane">Bent Fiane</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Gynecology and Gynecologic Oncology, Stavanger University Hospital, Stavanger, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Gynecology and Gynecologic Oncology, Stavanger University Hospital, Stavanger</wicri:regionArea>
<wicri:noRegion>Stavanger</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Monk, Bradley J" sort="Monk, Bradley J" uniqKey="Monk B" first="Bradley J" last="Monk">Bradley J. Monk</name>
<affiliation wicri:level="2"><nlm:affiliation>Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, Division of Gynecologic Oncology, Phoenix, AZ, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, Division of Gynecologic Oncology, Phoenix, AZ</wicri:regionArea>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Reinthaller, Alexander" sort="Reinthaller, Alexander" uniqKey="Reinthaller A" first="Alexander" last="Reinthaller">Alexander Reinthaller</name>
<affiliation wicri:level="3"><nlm:affiliation>Allgemeines Krankenhaus Wien, Dept. Gynecology and Obstetrics, Vienna, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Allgemeines Krankenhaus Wien, Dept. Gynecology and Obstetrics, Vienna</wicri:regionArea>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Calvert, Paula" sort="Calvert, Paula" uniqKey="Calvert P" first="Paula" last="Calvert">Paula Calvert</name>
<affiliation wicri:level="1"><nlm:affiliation>All-Ireland Co-operative Oncology Group, Dublin, Ireland.</nlm:affiliation>
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>All-Ireland Co-operative Oncology Group, Dublin</wicri:regionArea>
<wicri:noRegion>Dublin</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Herzog, Thomas J" sort="Herzog, Thomas J" uniqKey="Herzog T" first="Thomas J" last="Herzog">Thomas J. Herzog</name>
<affiliation wicri:level="2"><nlm:affiliation>University of Cincinnati Cancer Institute, Cincinnati, OH, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of Cincinnati Cancer Institute, Cincinnati, OH</wicri:regionArea>
<placeName><region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Meier, Werner" sort="Meier, Werner" uniqKey="Meier W" first="Werner" last="Meier">Werner Meier</name>
<affiliation wicri:level="3"><nlm:affiliation>Evangelisches Krankenhaus Düsseldorf, Düsseldorf, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Evangelisches Krankenhaus Düsseldorf, Düsseldorf</wicri:regionArea>
<placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Düsseldorf</region>
<settlement type="city">Düsseldorf</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kim, Jae Weon" sort="Kim, Jae Weon" uniqKey="Kim J" first="Jae-Weon" last="Kim">Jae-Weon Kim</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Obstetrics and Gynecology, Seoul National University, Seoul, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Seoul National University, Seoul</wicri:regionArea>
<placeName><settlement type="city">Séoul</settlement>
<region type="capital">Région capitale de Séoul</region>
<settlement type="city">Séoul</settlement>
</placeName>
<orgName type="university">Université nationale de Séoul</orgName>
</affiliation>
</author>
<author><name sortKey="Del Campo, Josep M" sort="Del Campo, Josep M" uniqKey="Del Campo J" first="Josep M" last="Del Campo">Josep M. Del Campo</name>
<affiliation wicri:level="3"><nlm:affiliation>Vall d'Hebron University Hospital, Dept. of Medical Oncology, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Vall d'Hebron University Hospital, Dept. of Medical Oncology, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Friedlander, Michael" sort="Friedlander, Michael" uniqKey="Friedlander M" first="Michael" last="Friedlander">Michael Friedlander</name>
<affiliation wicri:level="1"><nlm:affiliation>The Prince of Wales Cancer Center, Dept. of Medical Oncology, Randwick, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The Prince of Wales Cancer Center, Dept. of Medical Oncology, Randwick, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pisano, Carmela" sort="Pisano, Carmela" uniqKey="Pisano C" first="Carmela" last="Pisano">Carmela Pisano</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Uro-gynecologic Oncology, Istituto Nazionale Tumori Fondazione G Pascale-IRCCS, Naples, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Uro-gynecologic Oncology, Istituto Nazionale Tumori Fondazione G Pascale-IRCCS, Naples</wicri:regionArea>
<wicri:noRegion>Naples</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Isonishi, Seiji" sort="Isonishi, Seiji" uniqKey="Isonishi S" first="Seiji" last="Isonishi">Seiji Isonishi</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Obstetrics and Gynecology, Jikei University School of Medicine, Daisan Hospital, Tokyo, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Jikei University School of Medicine, Daisan Hospital, Tokyo</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Crescenzo, Rocco J" sort="Crescenzo, Rocco J" uniqKey="Crescenzo R" first="Rocco J" last="Crescenzo">Rocco J. Crescenzo</name>
<affiliation wicri:level="2"><nlm:affiliation>GlaxoSmithKline, Collegeville, PA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>GlaxoSmithKline, Collegeville, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Barrett, Catherine" sort="Barrett, Catherine" uniqKey="Barrett C" first="Catherine" last="Barrett">Catherine Barrett</name>
<affiliation wicri:level="1"><nlm:affiliation>GlaxoSmithKline Pharmaceuticals, Uxbridge, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>GlaxoSmithKline Pharmaceuticals, Uxbridge</wicri:regionArea>
<wicri:noRegion>Uxbridge</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wang, Karrie" sort="Wang, Karrie" uniqKey="Wang K" first="Karrie" last="Wang">Karrie Wang</name>
<affiliation wicri:level="2"><nlm:affiliation>GlaxoSmithKline, Collegeville, PA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>GlaxoSmithKline, Collegeville, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mitrica, Ionel" sort="Mitrica, Ionel" uniqKey="Mitrica I" first="Ionel" last="Mitrica">Ionel Mitrica</name>
<affiliation wicri:level="2"><nlm:affiliation>GlaxoSmithKline, Collegeville, PA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>GlaxoSmithKline, Collegeville, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Du Bois, Andreas" sort="Du Bois, Andreas" uniqKey="Du Bois A" first="Andreas" last="Du Bois">Andreas Du Bois</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Gynecology and Gynecologic Oncology, Kliniken Essen Mitte, Essen, Germany. Electronic address: prof.dubois@googlemail.com.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Gynecology and Gynecologic Oncology, Kliniken Essen Mitte, Essen</wicri:regionArea>
<wicri:noRegion>Essen</wicri:noRegion>
<wicri:noRegion>Essen</wicri:noRegion>
<wicri:noRegion>Essen</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Gynecologic oncology</title>
<idno type="eISSN">1095-6859</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Angiogenesis Inhibitors</term>
<term>Disease-Free Survival</term>
<term>Double-Blind Method</term>
<term>Endpoint Determination (methods)</term>
<term>Endpoint Determination (standards)</term>
<term>Fallopian Tube Neoplasms (drug therapy)</term>
<term>Fallopian Tube Neoplasms (mortality)</term>
<term>Fallopian Tube Neoplasms (surgery)</term>
<term>Female</term>
<term>Humans</term>
<term>Neoplasms, Glandular and Epithelial (drug therapy)</term>
<term>Neoplasms, Glandular and Epithelial (mortality)</term>
<term>Neoplasms, Glandular and Epithelial (surgery)</term>
<term>Ovarian Neoplasms (drug therapy)</term>
<term>Ovarian Neoplasms (mortality)</term>
<term>Ovarian Neoplasms (surgery)</term>
<term>Peritoneal Neoplasms (drug therapy)</term>
<term>Peritoneal Neoplasms (mortality)</term>
<term>Peritoneal Neoplasms (surgery)</term>
<term>Pyrimidines (therapeutic use)</term>
<term>Sulfonamides (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Détermination du point final ()</term>
<term>Détermination du point final (normes)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Inhibiteurs de l'angiogenèse</term>
<term>Méthode en double aveugle</term>
<term>Pyrimidines (usage thérapeutique)</term>
<term>Sulfonamides (usage thérapeutique)</term>
<term>Survie sans rechute</term>
<term>Tumeurs de l'ovaire ()</term>
<term>Tumeurs de l'ovaire (mortalité)</term>
<term>Tumeurs de l'ovaire (traitement médicamenteux)</term>
<term>Tumeurs de la trompe de Fallope ()</term>
<term>Tumeurs de la trompe de Fallope (mortalité)</term>
<term>Tumeurs de la trompe de Fallope (traitement médicamenteux)</term>
<term>Tumeurs du péritoine ()</term>
<term>Tumeurs du péritoine (mortalité)</term>
<term>Tumeurs du péritoine (traitement médicamenteux)</term>
<term>Tumeurs épithéliales épidermoïdes et glandulaires ()</term>
<term>Tumeurs épithéliales épidermoïdes et glandulaires (mortalité)</term>
<term>Tumeurs épithéliales épidermoïdes et glandulaires (traitement médicamenteux)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Pyrimidines</term>
<term>Sulfonamides</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Angiogenesis Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Fallopian Tube Neoplasms</term>
<term>Neoplasms, Glandular and Epithelial</term>
<term>Ovarian Neoplasms</term>
<term>Peritoneal Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Endpoint Determination</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Fallopian Tube Neoplasms</term>
<term>Neoplasms, Glandular and Epithelial</term>
<term>Ovarian Neoplasms</term>
<term>Peritoneal Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Tumeurs de l'ovaire</term>
<term>Tumeurs de la trompe de Fallope</term>
<term>Tumeurs du péritoine</term>
<term>Tumeurs épithéliales épidermoïdes et glandulaires</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Détermination du point final</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Endpoint Determination</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Fallopian Tube Neoplasms</term>
<term>Neoplasms, Glandular and Epithelial</term>
<term>Ovarian Neoplasms</term>
<term>Peritoneal Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs de l'ovaire</term>
<term>Tumeurs de la trompe de Fallope</term>
<term>Tumeurs du péritoine</term>
<term>Tumeurs épithéliales épidermoïdes et glandulaires</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Pyrimidines</term>
<term>Sulfonamides</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Disease-Free Survival</term>
<term>Double-Blind Method</term>
<term>Female</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Détermination du point final</term>
<term>Femelle</term>
<term>Humains</term>
<term>Inhibiteurs de l'angiogenèse</term>
<term>Méthode en double aveugle</term>
<term>Survie sans rechute</term>
<term>Tumeurs de l'ovaire</term>
<term>Tumeurs de la trompe de Fallope</term>
<term>Tumeurs du péritoine</term>
<term>Tumeurs épithéliales épidermoïdes et glandulaires</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Analysis of progression-free survival (PFS) as the primary endpoint in advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer (AEOC) trials may be confounded by the difficulty of radiologic evaluation of disease progression and the potential for discrepancy between investigator and blinded independent central assessments. PFS as assessed by local investigator (INV) was the primary endpoint of AGO-OVAR16, a randomized, double-blind trial of pazopanib maintenance therapy in AEOC. To confirm the robustness of the primary analysis, PFS was also evaluated by blinded independent central review (BICR).</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
<li>Australie</li>
<li>Autriche</li>
<li>Belgique</li>
<li>Corée du Sud</li>
<li>Espagne</li>
<li>France</li>
<li>Irlande (pays)</li>
<li>Italie</li>
<li>Japon</li>
<li>Norvège</li>
<li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region><li>Aquitaine</li>
<li>Arizona</li>
<li>Catalogne</li>
<li>District de Düsseldorf</li>
<li>Lombardie</li>
<li>Nouvelle-Aquitaine</li>
<li>Ohio</li>
<li>Pennsylvanie</li>
<li>Rhénanie-du-Nord-Westphalie</li>
<li>Région capitale de Séoul</li>
<li>Région de Kantō</li>
<li>Vienne (Autriche)</li>
</region>
<settlement><li>Barcelone</li>
<li>Bordeaux</li>
<li>Düsseldorf</li>
<li>Milan</li>
<li>Séoul</li>
<li>Tokyo</li>
<li>Vienne (Autriche)</li>
</settlement>
<orgName><li>Université nationale de Séoul</li>
</orgName>
</list>
<tree><country name="France"><region name="Nouvelle-Aquitaine"><name sortKey="Floquet, Anne" sort="Floquet, Anne" uniqKey="Floquet A" first="Anne" last="Floquet">Anne Floquet</name>
</region>
</country>
<country name="Belgique"><noRegion><name sortKey="Vergote, Ignace" sort="Vergote, Ignace" uniqKey="Vergote I" first="Ignace" last="Vergote">Ignace Vergote</name>
</noRegion>
</country>
<country name="Italie"><region name="Lombardie"><name sortKey="Colombo, Nicoletta" sort="Colombo, Nicoletta" uniqKey="Colombo N" first="Nicoletta" last="Colombo">Nicoletta Colombo</name>
</region>
<name sortKey="Pisano, Carmela" sort="Pisano, Carmela" uniqKey="Pisano C" first="Carmela" last="Pisano">Carmela Pisano</name>
</country>
<country name="Norvège"><noRegion><name sortKey="Fiane, Bent" sort="Fiane, Bent" uniqKey="Fiane B" first="Bent" last="Fiane">Bent Fiane</name>
</noRegion>
</country>
<country name="États-Unis"><region name="Arizona"><name sortKey="Monk, Bradley J" sort="Monk, Bradley J" uniqKey="Monk B" first="Bradley J" last="Monk">Bradley J. Monk</name>
</region>
<name sortKey="Crescenzo, Rocco J" sort="Crescenzo, Rocco J" uniqKey="Crescenzo R" first="Rocco J" last="Crescenzo">Rocco J. Crescenzo</name>
<name sortKey="Herzog, Thomas J" sort="Herzog, Thomas J" uniqKey="Herzog T" first="Thomas J" last="Herzog">Thomas J. Herzog</name>
<name sortKey="Mitrica, Ionel" sort="Mitrica, Ionel" uniqKey="Mitrica I" first="Ionel" last="Mitrica">Ionel Mitrica</name>
<name sortKey="Wang, Karrie" sort="Wang, Karrie" uniqKey="Wang K" first="Karrie" last="Wang">Karrie Wang</name>
</country>
<country name="Autriche"><region name="Vienne (Autriche)"><name sortKey="Reinthaller, Alexander" sort="Reinthaller, Alexander" uniqKey="Reinthaller A" first="Alexander" last="Reinthaller">Alexander Reinthaller</name>
</region>
</country>
<country name="Irlande (pays)"><noRegion><name sortKey="Calvert, Paula" sort="Calvert, Paula" uniqKey="Calvert P" first="Paula" last="Calvert">Paula Calvert</name>
</noRegion>
</country>
<country name="Allemagne"><region name="Rhénanie-du-Nord-Westphalie"><name sortKey="Meier, Werner" sort="Meier, Werner" uniqKey="Meier W" first="Werner" last="Meier">Werner Meier</name>
</region>
<name sortKey="Du Bois, Andreas" sort="Du Bois, Andreas" uniqKey="Du Bois A" first="Andreas" last="Du Bois">Andreas Du Bois</name>
</country>
<country name="Corée du Sud"><region name="Région capitale de Séoul"><name sortKey="Kim, Jae Weon" sort="Kim, Jae Weon" uniqKey="Kim J" first="Jae-Weon" last="Kim">Jae-Weon Kim</name>
</region>
</country>
<country name="Espagne"><region name="Catalogne"><name sortKey="Del Campo, Josep M" sort="Del Campo, Josep M" uniqKey="Del Campo J" first="Josep M" last="Del Campo">Josep M. Del Campo</name>
</region>
</country>
<country name="Australie"><noRegion><name sortKey="Friedlander, Michael" sort="Friedlander, Michael" uniqKey="Friedlander M" first="Michael" last="Friedlander">Michael Friedlander</name>
</noRegion>
</country>
<country name="Japon"><region name="Région de Kantō"><name sortKey="Isonishi, Seiji" sort="Isonishi, Seiji" uniqKey="Isonishi S" first="Seiji" last="Isonishi">Seiji Isonishi</name>
</region>
</country>
<country name="Royaume-Uni"><noRegion><name sortKey="Barrett, Catherine" sort="Barrett, Catherine" uniqKey="Barrett C" first="Catherine" last="Barrett">Catherine Barrett</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002957 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002957 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:25434635
   |texte=   Progression-free survival by local investigator versus independent central review: comparative analysis of the AGO-OVAR16 Trial.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:25434635" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

Serveur d'exploration sur les relations entre la France et l'Australie

Progression-free survival by local investigator versus independent central review: comparative analysis of the AGO-OVAR16 Trial.

Progression-free survival by local investigator versus independent central review: comparative analysis of the AGO-OVAR16 Trial.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.